# Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation

> **NCT03108872** · — · UNKNOWN · sponsor: **Sejong General Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** left atrial appendage occlusion
- **DRUG:** New oral anticoagulants

## Key facts

- **NCT ID:** NCT03108872
- **Lead sponsor:** Sejong General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-23
- **Primary completion:** 2017-09-30
- **Final completion:** 2017-10-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2017-05-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03108872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03108872, "Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03108872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*